Results 21 to 30 of about 168,078 (280)

Hepatitis B vaccine development and implementation

Human Vaccines & Immunotherapeutics, 2020
Vaccination against hepatitis B is the most effective strategy to control HBV infection. The first licensed hepatitis B vaccine was developed by the purification of hepatitis B surface antigen (HBsAg) from plasma of asymptomatic HBsAg carriers. Then, the
Hong Zhao, Xiaoying Zhou, Yi-Hua Zhou
doaj   +1 more source

Viral Hepatitis A, B and C in a Group of Transgender Women in Central Brazil

Tropical Medicine and Infectious Disease, 2022
Transgender women (TGW) have limited access to affordable viral hepatitis testing, hepatitis B vaccination, and treatment. We aimed to estimate the prevalence of viral hepatitis A, B, and C, as well as to compare the adherence and immunogenicity of two ...
Lucila Pessuti Ferri, Priscilla dos Santos Junqueira, Mayara Maria Souza de Almeida, Mariana Gomes Oliveira, Brunna Rodrigues de Oliveira, Bruno Vinícius Diniz e Silva, Larissa Silva Magalhães, Lívia Melo Villar, Karlla Antonieta Amorim Caetano, Márcia Maria Souza, Megmar Aparecida dos Santos Carneiro, Regina Maria Bringel Martins, Sheila Araujo Teles   +12 more
doaj   +1 more source

The role of provider characteristics on the hepatitis A and B vaccination status of adults in the United States during 2007–2015

Preventive Medicine Reports, 2019
Hepatitis A and B vaccine coverage is suboptimal in US adults, even among those at increased risk for infection, morbidity, or mortality. To understand where medical education and resources might enhance vaccine coverage, it is important to first ...
P.K. Ghaswalla, B.J. Patterson, W.Y. Cheng, E. Duchesneau, M. Macheca, M.S. Duh, A.F. Trofa   +6 more
doaj   +1 more source

Hepatitis B vaccine birth dose in India: time to reconsider

Human Vaccines & Immunotherapeutics, 2020
Viral hepatitis is increasingly being recognized as a public health problem in India with 96% of all hepatitis mortality attributed to hepatitis B and C combined.
Pragyan Paramita Parija, Mohan Kumar M
doaj   +1 more source

Immunogenicity and immunization costs of adjuvanted versus non-adjuvanted hepatitis B vaccine in chronic kidney disease patients [PDF]

, 2016
Hepatitis B virus (HBV) vaccination is recommended for all susceptible chronic pre-hemodialysis and hemodialysis patients. This study assessed the immunogenicity of HBV vaccines (adjuvanted and non ...
Aldea, Marta, Bayas Rodríguez, José María, García-Basteiro, Alberto L., Sequera, Víctor Guillermo, Sicuri, Elisa, Velasco Muñoz, César, Vilajeliu, Alba   +6 more
core   +1 more source

Physicians Infrequently Adhere to Hepatitis Vaccination Guidelines for Chronic Liver Disease [PDF]

, 2013
Background and Goals:Hepatitis A (HAV) and hepatitis B (HBV) vaccination in patients with chronic liver disease is an accepted standard of care. We determined HAV and HBV vaccination rates in a tertiary care referral hepatology clinic and the impact of ...
A Wasley, AE Fiore, B Hernandez, BL Innis, BW Sherman, Dhiraj Yadav, DT Lau, EB Keeffe, EB Keeffe, EE Mast, F Andre, H Pham, Jaideep Behari, JJ Ott, JN Zuckerman, John E. Tavis, JR Kramer, K Chamie, Kaitlyn Sweeney, Kavitha Thudi, LM Prevedello, MA Worns, PL Almasio, RJ Jacobs, RL Barclay, SH Woolf, W Szmuness, YF Liaw   +27 more
core   +5 more sources

Mandatory vaccinations in European countries, undocumented information, false news and the impact on vaccination uptake: the position of the Italian pediatric society. [PDF]

, 2018
BACKGROUND: High rates of vaccination coverage are important in preventing infectious diseases. Enforcing mandatory vaccinations is one of the strategies that some Countries adopted to protect the community when vaccination coverage is not satisfactory ...
Bozzola E, Bozzola M, Corsello G, Russo R, Spina G, Villani A   +5 more
core   +2 more sources

Research progress of hepatitis B virus and its vaccine [PDF]

BIO Web of Conferences
Hepatitis B is a serious worldwide public health problem with a very high incidence. It is caused by the hepatitis B virus (HBV), and vaccination is the primary preventive measure. However, vaccine non-response or weak immune responses remain a challenge.
Huang Zhenghuai
doaj   +1 more source

Hepatitis B Virus (HBV) and S-Escape Mutants: From the Beginning until Now [PDF]

, 2015
Despite of the progress made in vaccine and antiviral therapy development, hepatitis B virus (HBV) infection remains a major health care problem. More than 240 million people are chronically infected worldwide showing differences in the severity of liver
Cuestas, María Luján, Eguibar, Nair, Gonzalez, Rodrigo Horacio, Nusblat, Alejandro David, Perazzo, Priscila   +4 more
core   +1 more source

Hepatitis B vaccination [PDF]

BMJ, 2007
Hepatitis B virus is a substantial threat to global health, with 360 million people chronically infected and more than 500 000 deaths each year from fulminant hepatitis, cirrhosis, and liver cancer.1 2 After a call by the World Health Organization for the global introduction of vaccine prevention programmes by 1997,3 82% of countries in the world had ...
openaire   +4 more sources